Back to results
US 2017/0000866 A1Published application
Method for emulsifying a triepitope peptide with montanide and kits for performing the same
AssigneeVaxon Biotech
InventorJeanne Menez-Jamet
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method for preparing a vaccine formulation with an optimized polypeptide comprising three epitopes and MONTANIDE as adjuvant, for use in anti-cancer immunotherapy for administration to a human subject.
Claims15
A method of obtaining a water in oil emulsion for administration of a polypeptide of sequence YLQVNSLQTVYLEYRQVPVYLEEITGYL (SEQ ID NO:
- 1) to a human subject, comprising:
- (i) obtaining an aqueous antigenic phase by dissolving lyophilized polypeptide of SEQ ID NO:
- 1 in pure sterile water;
- (ii) loading one volume of said aqueous antigenic phase and one volume of MONTANIDE ISA 51 into a device comprising two syringes linked by a connector;
- (iii) pre-emulsifying the formulation by performing at least three cycles of transfer of the whole formulation from one syringe to the other and then back to the first syringe, wherein each cycle lasts at least 6 seconds;
- and
- (iv) emulsifying the formulation by performing at least 20 additional transfer cycles, wherein each cycle lasts at most 2 seconds.
4 more elements
A water in oil emulsion containing the polypeptide of SEQ ID NO:
- 1 and MONTANIDE ISA 51, wherein the peptide concentration in said emulsion is in the range 1 to 10 mg/ml, and wherein the Dv 50 of the emulsion is below 3 μm.
Dependencies are inferred from the claim text.